Variations in the Use of Prostate Cancer Staging Tests: Results from One NGGN Institution

Charles L. Bennett, Teresa Yang, Robert Nadler

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Medical care for prostate cancer accounts for as much as $26 billion in medical expenditures. There is debate about whether urologists who treat a large number of cases of prostate cancer use medical resources more efficiently than do urologists who treat fewer patients. This study focuses on one aspect of this debate by addressing the following issue: Are men with prostate cancer more likely to undergo noninvasive staging tests when they are treated by urologists who have higher caseloads than urologists with lower caseloads? Our study identified variations in patterns of ordering staging tests for prostate cancer. The finding supports the use of guidelines. Adherence to the guidelines is likely to be associated with more efficient use of medical resources by physicians with lower caseloads of prostate cancer.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
Issue number11 SUPPL. 11A
StatePublished - Dec 1 1997

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Variations in the Use of Prostate Cancer Staging Tests: Results from One NGGN Institution'. Together they form a unique fingerprint.

Cite this